Publications
75
Citations
1,016
Est. group size
~1
Recurring co-author estimate
Active years
26
Publishing since 2001
Patrick J. Kiel's work spans oncology pharmacy practice and clinical pharmacology, focusing on how cancer drugs and antibiotics are dosed and used in real-world patient care. Much of the research examines cefepime (an antibiotic) dosing strategies using population and statistical models, alongside studies on precision oncology practices such as biomarker testing, targeted cancer therapies, and pharmacist roles in cancer clinics. Recent work uses large real-world datasets, including the NIH All of Us Research Program, to study treatment patterns and outcomes in colorectal, lung, and prostate cancers.
Publication output was relatively steady from 2017-2020 (6-10 per year) but dropped sharply from 2021-2024 before a modest resurgence in 2025-2026.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- National Patterns of Biomarker Testing in Colorectal, Lung, and Prostate Cancers: Insights From the NIH <i>All of Us</i> Research Program
Clinical Medicine Insights Oncology · 2026
- ACCESS, OUTCOMES, AND ECONOMIC PERSPECTIVES IN PRECISION ONCOLOGY: REAL-WORLD EVIDENCE ON BIOMARKER TESTING AND TARGETED THERAPY FROM THE NIH <i>ALL OF</i> <i>US</i> PROGRAM
Open MIND · 2026
- ACCESS, OUTCOMES, AND ECONOMIC PERSPECTIVES IN PRECISION ONCOLOGY: REAL-WORLD EVIDENCE ON BIOMARKER TESTING AND TARGETED THERAPY FROM THE NIH <i>ALL OF</i> <i>US</i> PROGRAM
Purdue · 2026
- Time to Treatment Discontinuation and Cost Effectiveness of Third-Line Therapies in Advanced Colorectal Cancer: Real-World Evidence from the NIH All of Us Research Program
Drugs - Real World Outcomes · 2026
- Defining Optimal Sampling Strategies for Cefepime Model-Informed Precision Dosing
Therapeutic Drug Monitoring · 2026
- 211. Defining Optimal Sampling Times for Cefepime Therapeutic Drug Monitoring in Clinical Practice
Open Forum Infectious Diseases · 2025
- Development of Population and Bayesian Models for Applied Use in Patients Receiving Cefepime
Clinical Pharmacokinetics · 2020
- β-lactam dosing strategies: Think before you push
International Journal of Antimicrobial Agents · 2020
- Precision Genomic Practice in Oncology: Pharmacist Role and Experience in an Ambulatory Care Clinic
Pharmacy · 2020
- Virtually there: An innovative approach for training oncology pharmacy residents in gynecologic oncology
Journal of the American Pharmacists Association · 2020
- Development of population and Bayesian models for applied use in patients receiving cefepime
medRxiv · 2019
- 2017-2018 Drug Approvals in Solid Tumors
Journal of the Advanced Practitioner in Oncology · 2019
- 1573. Population Pharmacokinetic Analyses for Cefepime in Adult and Pediatric Patients
Open Forum Infectious Diseases · 2019
- Enasidenib: An Oral IDH2 Inhibitor for the Treatment of Acute Myeloid Leukemia
Journal of the Advanced Practitioner in Oncology · 2018
- Assessment of bleeding incidences associated with rivaroxaban therapy in adults with solid tumors
Journal of Oncology Pharmacy Practice · 2018
- Journal of the Advanced Practitioner in Oncology×4
- JCO Precision Oncology×3
- International Journal of Antimicrobial Agents×2
- Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy×2
- PMC×2
- Patrick Elder
Medicine · The Ohio State University
- Julianna Roddy
Medicine · The Ohio State University
- Jennifer E. Schwartz
Medicine · Indiana University
- Justin Jiang
Medicine · The Ohio State University
- Hannah Choe
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile